Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Singapore

Singapore: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 91.0% in 2025. ▲ Rising

Latest (2025)
91.0%
Change on year
unchanged
World rank
61st
of 194 countries
All-time high
93.0%
in 2023
All-time low
0.0%
in 2008
Years of data
18
2008–2025

Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Singapore, 2008–2025

0204060801002008201620252008: 02009: 172010: 222011: 402012: 522013: 602014: 682015: 752016: 782017: 832018: 842019: 842020: 872021: 882022: 902023: 932024: 912025: 91

Source: World Health Organization, Global Health Observatory.

Analysis

Singapore recorded 91.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in 2025.

Compared with earlier readings it is up 21.3% over ten years.

Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Singapore peaked at 93.0% in 2023 and was at its lowest, 0.0%, in 2008.

Singapore ranks 61st of 194 countries on this measure, in the middle of the range.

The long-run direction has been consistently rising across the 18 years of available data.

Averages by decade

DecadeAverage LowestHighest Years
2000s 8.5% 0.0% 17.0% 2
2010s 64.6% 22.0% 84.0% 10
2020s 90.0% 87.0% 93.0% 6

Countries ranked near Singapore

  1. 61 Serbia 91.0% compare
  2. 61 Paraguay 91.0% compare
  3. 61 Zimbabwe 91.0% compare
  4. 61 United Arab Emirates 91.0% compare
  5. 61 Finland 91.0% compare
  6. 61 Burkina Faso 91.0% compare
  7. 61 Senegal 91.0% compare
  8. 61 Malawi 91.0% compare

See the full ranking of 206 places →

More health data for Singapore

All data for Singapore →

Frequently asked questions

What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Singapore?
Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Singapore was 91.0% in 2025, according to World Health Organization, Global Health Observatory.
What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Singapore?
The highest recorded value was 93.0% in 2023.
What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Singapore?
The lowest recorded value was 0.0% in 2008.
How does Singapore rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
Singapore ranks 61st out of 194 countries with data for 2025.
Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Singapore?
Over the last ten years it is up 21.3%. The long-run trend across the full record is rising.
Where does this Singapore data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed